Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Markus Dieterle"'
Autor:
Dilan Sezer, Matthijs de Leeuw, Cordula Netzer, Markus Dieterle, Andrea Meyer, Sarah Buergler, Cosima Locher, Wilhelm Ruppen, Jens Gaab, Tobias Schneider
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on
Externí odkaz:
https://doaj.org/article/f63fce32e34740b9bd3962ad2897def8
Autor:
Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, Katja Mercer-Chalmers-Bender, Priska Frei, Wilhelm Ruppen, Tobias Schneider
Publikováno v:
Pain. 163:1919-1928
Opioids in general and remifentanil in particular can induce hyperalgesia. Preclinical data suggest that cannabidiol might have the capacity to reduce opioid-induced hyperalgesia (OIH). Thus, we investigated the effect of oral cannabidiol on OIH in h
Autor:
Tobias Schneider, Wilhelm Ruppen, Cordula Netzer, Andrea H. Meyer, Markus Dieterle, Matthijs de Leeuw, Jens Gaab, Dilan Sezer, Cosima Locher, Sarah Buergler
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine
Frontiers in Medicine
Introduction: Open-label placebos have been proposed as way of using long recognized analgesic placebo effects in an ethical manner. Recent evidence shows efficacy of open-label placebos for clinical conditions, but there is need for more research on
Autor:
Wilhelm Ruppen, Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, Priska Frei, Tobias Schneider, Katja Mercer-Chalmers-Bender
Publikováno v:
Pain. 163(1)
Preclinical studies have demonstrated the analgesic potential of cannabidiol (CBD). Those suggesting an effect on pain-processing receptors have brought CBD back into focus. This study assessed the effect of CBD on acute pain, hyperalgesia, and allod